Pure Global
DRKS00028934

Crossover in vivo study: investigation of the redox status of study participants before and after ingestion of vitamin C in blood.

Charité-Universitätsmedizin Berlin, Dermatologie10117 BerlinGermany·Deutsches Register Klinischer StudienRecruitment Completed
Study focus
Disease/Condition
None ;Healthy volunteers
Study type
Interventional
Sponsor & location
Primary sponsor
Charité-Universitätsmedizin Berlin, Dermatologie10117 BerlinGermany
Location
Germany
Timeline & enrollment
Phase
N/A
Start date
N/A
End date
N/A
Summary

The aim of the in vivo study is to show that an increase in the vitamin C dose in physiological concentrations leads to anti-oxidative protection, which can be demonstrated quantitatively/qualitatively in the blood. However, if the critical vitamin C concentration is exceeded, there may be an increase in radical production (pro-oxidative effect) or saturation or a shift in the proportion of radical species.

ICD-10 classifications
Healthy person accompanying sick personRoutine general health check-up of armed forcesRoutine general health check-up of sports teamsRoutine general health check-up of inhabitants of institutions
Data source
Registry
Deutsches Register Klinischer Studien
Trial ID
DRKS00028934
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for DRKS00028934 through Pure Global AI's free database. This phase not specified trial is sponsored by Charité-Universitätsmedizin Berlin, Dermatologie10117 BerlinGermany and is currently Recruitment Completed. The study focuses on None ;Healthy volunteers.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Deutsches Register Klinischer Studien data, helping medical device and pharmaceutical companies navigate clinical research efficiently.